For the first time, researchers have used human data to quantify the speed of different processes that lead to Alzheimer’s disease and found that it develops in a very different way than previously thought. Their results could have important implications for the development of potential treatments.
When Madeline Lancaster’s attempt to grow neural stem cells ‘failed’ she had no idea that the floating balls of cells she saw in her petri dish were in fact miniature brain tissues. They would revolutionise our ability to study the early stages of brain development and take us closer to answering: what makes us human?
Researchers from the Cancer Research UK Cambridge Institute have developed two tests that can detect the presence of glioma, a type of brain tumour, in patient urine or blood plasma.
Scientists at Cambridge and Leeds have successfully reversed age-related memory loss in mice and say their discovery could lead to the development of treatments to prevent memory loss in people as they age.
A team of engineers and clinicians has developed an ultra-thin, inflatable device that can be used to treat the most severe forms of pain without the need for invasive surgery.
Researchers have shown why people with mental health disorders, including anorexia and panic disorders, experience physical signals differently.
Scientists have made a ‘vital step’ towards understanding the origins of Parkinson’s disease – the fastest growing neurological condition in the world.
Study shows how to determine the elusive motions of proteins that remain disordered.
A new study suggests that it is possible to design drugs that can target a type of shape-shifting protein involved in Alzheimer’s disease, which was previously thought to be undruggable.
Fourteen out of every 1,000 COVID-19 patients admitted to hospital experience a stroke, a rate that is even higher in older patients and those with severe infection and pre-existing vascular conditions, according to a report published this week.
© 2025 University of Cambridge